Sphera Funds Management Ltd. Assembly Biosciences, Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$10.27 - $21.23 $906,306 - $1.87 Million	-88,248 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$8.36 - $23.81 $265,446 - $756,015	-31,752 Reduced 26.46%	88,248 $1.81 Million
Q3 2019 Nov 14, 2019	BUY	$9.83 - $14.82 $1.18 Million - $1.78 Million	120,000 New	120,000 $1.18 Million
Q4 2018 Feb 14, 2019	SELL	$19.05 - $36.45 $1.91 Million - $3.66 Million	-100,431 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $3.46 Million - $4.44 Million	100,431 New	100,431 $3.73 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.